Title : Vandetanib inhibits cell growth in EGFR-expressing cutaneous squamous cell carcinoma.

Pub. Date : 2020 Oct 20

PMID : 32800552






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Vandetanib inhibits cell growth in EGFR-expressing cutaneous squamous cell carcinoma. vandetanib epidermal growth factor receptor Homo sapiens
2 Vandetanib is a multiple tyrosine kinase targeting vascular endothelial growth factor receptor-2 (VEGFR2), EGFR, and the rearranged during transfection (RET) proto-oncogene. vandetanib epidermal growth factor receptor Homo sapiens
3 Mechanistically, vandetanib suppresses the phosphorylation of EGFR in SCC cells. vandetanib epidermal growth factor receptor Homo sapiens
4 In conclusion, we identified vandetanib as a novel therapeutic option for cutaneous SCC, especially in tumors with high EGFR expression. vandetanib epidermal growth factor receptor Homo sapiens